Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks

Atorvastatin 40 mg (ATOR 40) and ezetimibe 10 mg/simvastatin 20 mg (EZ-SIM 20) have similar reductions of low-density lipoprotein cholesterol (LDL-C) but cardiovascular (CV) outcomes between these two therapies are unclear. Our real-world cohort study is to test the hypothesis of pleiotropic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Yu-Cheng, Chen, Tien-Hsing, Liu, Chi-Hung, Hwang, Jawl-Shan, Hsiao, Ching-Chung, Lin, Yu-Sheng, Mao, Chun-Tai, Hung, Ming-Jui, Li, Yan-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988142/
https://www.ncbi.nlm.nih.gov/pubmed/33758291
http://dx.doi.org/10.1038/s41598-021-86090-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988142/
https://www.ncbi.nlm.nih.gov/pubmed/33758291
http://dx.doi.org/10.1038/s41598-021-86090-9

Ejemplares similares